134 assets in Hematopoietic And Lymphoid System Neoplasm

Therapeutic assets addressing Hematopoietic And Lymphoid System Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Favezelimab Hematopoietic And Lymphoid System Neoplasm	Merck Sharp & Dohme LLC	P3	CCC (54)
gt719 Hematopoietic And Lymphoid System Neoplasm	Grit Biotechnology	P1/2	CCC (54)
Ivosidenib Hematopoietic And Lymphoid System Neoplasm	M.D. Anderson Cancer Center	P1/2	CCC (54)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine Hematopoietic And Lymphoid System Neoplasm	City of Hope Medical Center	P2	CCC (54)
Romiplostim Hematopoietic And Lymphoid System Neoplasm	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P2	CCC (54)
Apalutamide Hematopoietic And Lymphoid System Neoplasm	Helsinki University Central Hospital	P2	CCC (53)
Bendamustine Hematopoietic And Lymphoid System Neoplasm	Yale University	P2	CCC (53)
Copanlisib Hematopoietic And Lymphoid System Neoplasm	OHSU Knight Cancer Institute	P2	CCC (53)
Mit-001 Hematopoietic And Lymphoid System Neoplasm	MitoImmune Therapeutics	P2	CCC (53)
Pemigatinib Hematopoietic And Lymphoid System Neoplasm	Helsinki University Central Hospital	P2	CCC (53)
Selpercatinib Hematopoietic And Lymphoid System Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Siltuximab Hematopoietic And Lymphoid System Neoplasm	Yuanquan Yang	P2	CCC (53)
Synthetic Mva-Based Sars-Cov-2 Vaccine Geo-Cm04S1 Hematopoietic And Lymphoid System Neoplasm	GeoVax, Inc.	P2	CCC (53)
Talazoparib Hematopoietic And Lymphoid System Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Tepotinib Hematopoietic And Lymphoid System Neoplasm	Helsinki University Central Hospital	P2	CCC (53)
Icp-248 Hematopoietic And Lymphoid System Neoplasm	Beijing InnoCare Pharma Tech Co., Ltd.	P2/3	CCC (52)
Orelabrutinib Hematopoietic And Lymphoid System Neoplasm	Beijing InnoCare Pharma Tech Co., Ltd.	P2/3	CCC (52)
Nemtabrutinib Hematopoietic And Lymphoid System Neoplasm	Merck Sharp & Dohme LLC	P2	CCC (51)
Capmatinib Hematopoietic And Lymphoid System Neoplasm	Cancer Research UK	P2/3	CCC (50)
Cephalotaxine 4-Methyl (2R)-2-Hydroxy-2-(4-Hydroxy-4-Methylpentyl)Butanedioate (Ester) Hematopoietic And Lymphoid System Neoplasm	University of Illinois at Chicago	P1	CCC (50)
Allogeneic Car19 Regulatory T Cells Hematopoietic And Lymphoid System Neoplasm	Masonic Cancer Center, University of Minnesota	P1/2	CCC (48)
Allogeneic T Cell Progenitors, Cultured Ex-Vivo Hematopoietic And Lymphoid System Neoplasm	Smart Immune SAS	P1/2	CCC (48)
DS3790a Hematopoietic And Lymphoid System Neoplasm	Daiichi Sankyo	P1/2	CCC (48)
Emavusertib Hematopoietic And Lymphoid System Neoplasm	Curis, Inc.	P1/2	CCC (48)
Ibrutinib Hematopoietic And Lymphoid System Neoplasm	Curis, Inc.	P1/2	CCC (48)
ict01 Hematopoietic And Lymphoid System Neoplasm	ImCheck Therapeutics	P1/2	CCC (48)
Immunoglobulin G2, Anti-(Human Ctla-4 (Antigen)) (Human Monoclonal Cp-675206 Clone 11.2.1 Heavy Chain) Disulphide With Human Monoclonal Cp-675206 Clone 11.2.1 Light Chain, Dimer Hematopoietic And Lymphoid System Neoplasm	AstraZeneca	P1/2	CCC (48)
rd13-02 cell infusion Hematopoietic And Lymphoid System Neoplasm	Kai Lin Xu，MD	Early P1	CCC (48)
Daratumumab Hematopoietic And Lymphoid System Neoplasm	Indapta Therapeutics, INC.	P1/2	CC (47)
Elranatamab Hematopoietic And Lymphoid System Neoplasm	CellCentric Ltd.	P1/2	CC (47)
Idp-023 Hematopoietic And Lymphoid System Neoplasm	Indapta Therapeutics, INC.	P1/2	CC (47)
Inobrodib Hematopoietic And Lymphoid System Neoplasm	CellCentric Ltd.	P1/2	CC (47)
Isatuximab Hematopoietic And Lymphoid System Neoplasm	Indapta Therapeutics, INC.	P1/2	CC (47)
Pomalidomide Hematopoietic And Lymphoid System Neoplasm	CellCentric Ltd.	P1/2	CC (47)
Tagraxofusp Hematopoietic And Lymphoid System Neoplasm	Jacqueline Garcia, MD	P1/2	CC (47)
Tuvusertib Hematopoietic And Lymphoid System Neoplasm	National Cancer Institute (NCI)	P1/2	CC (45)
Enitociclib Hematopoietic And Lymphoid System Neoplasm	National Cancer Institute (NCI)	P1/2	CC (44)
Abbv-101 Hematopoietic And Lymphoid System Neoplasm	AbbVie	P1	CC (43)
Atg-018 Hematopoietic And Lymphoid System Neoplasm	Antengene Discovery Limited	P1	CC (43)
Atorvastatin Hematopoietic And Lymphoid System Neoplasm	Joaquina Baranda	P1	CC (43)
Camibirstat Hematopoietic And Lymphoid System Neoplasm	Foghorn Therapeutics Inc.	P1	CC (43)
Cart-19 Cells Hematopoietic And Lymphoid System Neoplasm	University College, London	P1	CC (43)
cn202 Hematopoietic And Lymphoid System Neoplasm	Curon Biopharmaceutical (Australia) Co Pty Ltd	P1/2	CC (43)
Cytarabine Hematopoietic And Lymphoid System Neoplasm	Senti Biosciences	P1	CC (43)
Decitabine Hematopoietic And Lymphoid System Neoplasm	Foghorn Therapeutics Inc.	P1	CC (43)
dxc006 Hematopoietic And Lymphoid System Neoplasm	Hangzhou DAC Biotechnology Co., Ltd.	P1	CC (43)
Enzomenib Hematopoietic And Lymphoid System Neoplasm	Sumitomo Pharma America, Inc.	P1	CC (43)
hdm2005 Hematopoietic And Lymphoid System Neoplasm	Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.	P1	CC (43)
Ot-A201 Hematopoietic And Lymphoid System Neoplasm	Onward Therapeutics	P1	CC (43)
Plerixafor Hematopoietic And Lymphoid System Neoplasm	Stanford University	P1	CC (43)

Showing 51 to 100 of 134 assets

PreviousPage 2 of 3Next